quinacrine has been researched along with Leukemia, T-Cell in 1 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, HG | 1 |
| Fok, KS | 1 |
| Fendly, BM | 1 |
| Chiang, NY | 1 |
| Sussman, HH | 1 |
1 other study available for quinacrine and Leukemia, T-Cell
| Article | Year |
|---|---|
Activation of TNF-R1 receptor in the presence of copper kills TNF resistant CEM leukemic T cells.
Topics: Animals; Cell Line; Cell Survival; Copper; Drug Synergism; Flow Cytometry; Hydrogen-Ion Concentratio | 1994 |